[1] Wang ML, Cao RY, Zhang LK, et al. remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro[J]. Cell Res,2020, 30(3): 269–271. doi:  10.1038/s41422-020-0282-0
[2] Mwololo SW, Mutiso JM, Macharia JC, et al. In vitro activity and in vivo efficacy of a combination therapy of diminazene and chloroquine against murine visceral leishmaniasis[J]. J Biomed Res,2015, 29(3): 214–223. doi:  10.7555/JBR.29.20140072
[3] Muralidharan N, Sakthivel R, Velmurugan D, et al. Computational studies of drug repurposing and synergism of lopinavir, oseltamivir and ritonavir binding with SARS-CoV-2 protease against COVID-19[J]. J Biomol Struct Dyn,2020. doi:  10.1080/07391102.2020.1752802. [Epub ahead of print
[4] Xue XY, Yu HW, Yang HT, et al. Structures of two coronavirus main proteases: implications for substrate binding and antiviral drug design[J]. J Virol,2008, 82(5): 2515–2527. doi:  10.1128/JVI.02114-07
[5] Xu XT, Chen P, Wang JF, et al. Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission[J]. Sci China Life Sci,2020, 63(3): 457–460. doi:  10.1007/s11427-020-1637-5
[6] Zhao D, Wang ZM, Wang LS. Prevention of atrial fibrillation with renin-angiotensin system inhibitors on essential hypertensive patients: a meta-analysis of randomized controlled trials[J]. J Biomed Res,2015, 29(6): 475–485. doi:  10.7555/JBR.29.20140149
[7] Kumar Ramanathan AS, Karuppiah B, Vijayan M, et al. Effect of angiotensin converting enzyme gene I/D polymorphism in South Indian children with nephrotic syndrome[J]. J Biomed Res,2019, 33(3): 201–207. doi:  10.7555/JBR.32.20150095
[8] Zhang YZ. Initial genome release of novel coronavirus[EB/OL]. [2020-01-10]. http://virological.org/t/initial-genome-release-of-novel-coronavirus/319?from=groupmessage.
[9] Morse JS, Lalonde T, Xu SQ, et al. Learning from the past: possible urgent prevention and treatment options for severe acute respiratory infections caused by 2019-nCoV[J]. Chembiochem,2020, 21(5): 730–738. doi:  10.1002/cbic.202000047
[10] Dong N, Yang XM, Ye LW, et al. Genomic and protein structure modelling analysis depicts the origin and infectivity of 2019-nCoV, a new coronavirus which caused a pneumonia outbreak in Wuhan, China[EB/OL]. [2020-01-21]. https://www.biorxiv.org/content/10.1101/2020.01.20.913368v1.
[11] Wrapp D, Wang NS, Corbett KS, et al. Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation[J]. Science,2020, 367(6483): 1260–1263. doi:  10.1126/science.abb2507
[12] Waterhouse A, Bertoni M, Bienert S, et al. SWISS-MODEL: homology modelling of protein structures and complexes[J]. Nucleic Acids Res,2018, 46(W1): W296–W303. doi:  10.1093/nar/gky427
[13] Bienert S, Waterhouse A, de Beer TAP, et al. The SWISS-MODEL Repository-new features and functionality[J]. Nucleic Acids Res,2017, 45(D1): D313–D319. doi:  10.1093/nar/gkw1132
[14] Bertoni M, Kiefer F, Biasini M, et al. Modeling protein quaternary structure of homo- and hetero-oligomers beyond binary interactions by homology[J]. Sci Rep,2017, 7(1): 10480. doi:  10.1038/s41598-017-09654-8
[15] Ikram S, Ahmad J, Durdagi S. Screening of FDA approved drugs for finding potential inhibitors against Granzyme B as a potent drug-repurposing target[J]. J Mol Graph Model,2020, 95: 107462. doi:  10.1016/j.jmgm.2019.107462
[16] Kondagari B, Dulapalli R, Krishna Murthy D, et al. Towards the virtual screening of BIK inhibitors with the homology-modeled protein structure[J]. Med Chem Res,2013, 22(3): 1184–1196. doi:  10.1007/s00044-012-0105-z
[17] Kumar S, Jena L, Mohod K, et al. Virtual screening for potential inhibitors of high-risk human papillomavirus 16 E6 protein[J]. Interdiscip Sci Comput Life Sci,2015, 7(2): 136–142. doi:  10.1007/s12539-015-0008-z
[18] Umamaheswari A, Pradhan D, Hemanthkumar M. Virtual screening for potential inhibitors of homology modeled Leptospira interrogans MurD ligase[J]. J Chem Biol,2010, 3(4): 175–187. doi:  10.1007/s12154-010-0040-8
[19] Tan WSD, Liao WP, Zhou S, et al. Targeting the renin-angiotensin system as novel therapeutic strategy for pulmonary diseases[J]. Curr Opin Pharmacol,2018, 40: 9–17. doi:  10.1016/j.coph.2017.12.002
[20] MD simulated (37 °C, water, all-atom) model of Spike-ACE2(Spike is a homo-trimer in color, human ACE2 is in yellow)[EB/OL]. [2020-06-19]. https://ghddi-ailab.github.io/Targeting2019-nCoV/nCov_Structures/.
[21] Spitzer R, Jain AN. Surflex-dock: docking benchmarks and real-world application[J]. J Comput Aided Mol Des,2012, 26(6): 687–699. doi:  10.1007/s10822-011-9533-y
[22] Tripos Inc. SYBYL-X 1.3[EB/OL]. [2011-07-14]. https://sybyl-x.software.informer.com/1.3/.
[23] Zhang G, Guo S, Cui HQ, et al. Virtual screening of small molecular inhibitors against DprE1[J]. Molecules,2018, 23(3): 524. doi:  10.3390/molecules23030524
[24] Case DA, Betz RM, Cerutti DS, et al. AMBER 2016[CP]. San Francisco, CA: University of California, 2016.
[25] Jorgensen WL, Chandrasekhar J, Madura JD. Comparison of simple potential functions for simulating liquid water[J]. J Chem Phys,1983, 79(2): 926–935. doi:  10.1063/1.445869
[26] de Souza ON, Ornstein RL. Effect of periodic box size on aqueous molecular dynamics simulation of a DNA dodecamer with particle-mesh Ewald method[J]. Biophys J,1997, 72(6): 2395–2397. doi:  10.1016/S0006-3495(97)78884-2
[27] Berendsen HJC, Postma JPM, van Gunsteren WF, et al. Molecular dynamics with coupling to an external bath[J]. J Chem Phys,1984, 81(8): 3684–3690. doi:  10.1063/1.448118
[28] Ryckaert JP, Ciccotti G, Berendsen HJC. Numerical integration of the Cartesian equations of motion of a system with constraints: molecular dynamics of n-alkanes[J]. J Comput Phys,1977, 23(3): 327–341. doi:  10.1016/0021-9991(77)90098-5
[29] Duan Y, Wu C, Chowdhury S, et al. A point-charge force field for molecular mechanics simulations of proteins based on condensed-phase quantum mechanical calculations[J]. J Comput Chem,2003, 24(16): 1999–2012. doi:  10.1002/jcc.10349
[30] Frisch MJ, Trucks GW, Schlegel HB, et al. Gaussian 09 (revision D.01)[CP]. Wallingford, CT: Gaussian Inc., 2009.
[31] Wang JM, Wolf RM, Caldwell JW, et al. Development and testing of a general amber force field[J]. J Comput Chem,2004, 25(9): 1157–1174. doi:  10.1002/jcc.20035
[32] Brice AR, Dominy BN. Analyzing the robustness of the MM/PBSA free energy calculation method: application to DNA conformational transitions[J]. J Comput Chem,2011, 32(7): 1431–1440. doi:  10.1002/jcc.21727
[33] Negri M, Recanatini M, Hartmann RW. Computational investigation of the binding mode of bis(hydroxylphenyl)arenes in 17β-HSD1: molecular dynamics simulations, MM-PBSA free energy calculations, and molecular electrostatic potential maps[J]. J Comput Aided Mol Des,2011, 25(9): 795–811. doi:  10.1007/s10822-011-9464-7
[34] Chéron N, Shakhnovich EI. Effect of sampling on BACE-1 ligands binding free energy predictions via MM-PBSA calculations[J]. J Comput Chem,2017, 38(22): 1941–1951. doi:  10.1002/jcc.24839
[35] Li GD, de Clercq E. Therapeutic options for the 2019 novel coronavirus (2019-nCoV)[J]. Nat Rev Drug Discov,2020, 19(3): 149–150. doi:  10.1038/d41573-020-00016-0